Advances in imaging of uveitis
- PMID: 32524072
- PMCID: PMC7235656
- DOI: 10.1177/2515841420917781
Advances in imaging of uveitis
Abstract
Advances in multimodal imaging have significantly contributed to the management of many uveitis diseases in recent years. The most significant developments include the use of optical coherence tomography to obtain a more accurate and reproducible assessment of ocular inflammation, the application of optical coherence tomography angiography in choroiditis and retinal vasculitis, new possibilities for studying vitritis with ultrawide field imaging, and the most recent applications of fundus autofluorescence in uveitis. In this review, we provide an overview of the most significant advances in multimodal imaging of uveitis achieved in recent years.
Keywords: fundus autofluorescence; optical coherence tomography; optical coherence tomography angiography; ultrawide field imaging; uveitis.
© The Author(s), 2020.
Conflict of interest statement
Conflict of interest statement: AM, AA, AGM, SH, GM, VG and EM have no disclosures. GQ has the following disclosures: Allergan (S), Bayer (S); Novartis (S), Zeiss (S), Allergan (C), Alimera (C), Bausch and Lomb (C), Novartis (C), Bayer (C), Heidelberg (C), and Zeiss (C). F.B. has the following disclosures: Allergan (S), Alimera (S), Bayer (S), Farmila-Thea (S), Schering Pharma (S), Sanofi-Aventis (S), Novagali (S), Pharma (S), Hoffmann-La Roche (S), Genetech (S), and Novartis (S).
Figures
References
-
- Giuffre C, Miserocchi E, Modorati G, et al. Central serous chorioretinopathylike mimicking multifocal vitelliform macular dystrophy: an ocular side effect of mitogen/extracellular signal-regulated kinase inhibitors. Retin Cases Brief Rep 2018; 12: 172–176. DOI: 10.1097/ICB.0000000000000491. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
